A Pilot Randomized Clinical Trial of a Multidisciplinary Intervention for Encopresis in Children with Autism Spectrum Disorder

J Autism Dev Disord. 2020 Mar;50(3):757-765. doi: 10.1007/s10803-019-04305-5.

Abstract

Children with autism spectrum disorder (ASD) are often delayed in achieving bowel continence, resulting in negative outcomes. In this pilot trial, 20 children with ASD and encopresis were randomly assigned to multidisciplinary intervention for encopresis (MIE; n = 10) or a waitlist control group (n = 10). The MIE group was treated for constipation and received a 10-day behavioral intervention that utilized suppositories to produce predictable bowel movements that were reinforced. Caregivers were trained to implement the intervention. Results support the feasibility of clinical trials of MIE, with high enrolment, competition, attendance, and caregiver acceptability. Preliminary outcomes were positive, with six of 10 in the MIE group achieving continence by the end of treatment compared to 0 in the control group (p = 0.005).Registered at clinicaltrials.gov (https://clinicaltrials.gov); ID: NCT02383732.

Keywords: Encopresis; Multidisciplinary treatment; Pediatric gastroenterology.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Autism Spectrum Disorder / complications*
  • Behavior Therapy / methods*
  • Child
  • Child, Preschool
  • Combined Modality Therapy / methods
  • Encopresis / complications
  • Encopresis / drug therapy
  • Encopresis / therapy*
  • Female
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Pilot Projects
  • Suppositories / therapeutic use

Substances

  • Gastrointestinal Agents
  • Suppositories

Associated data

  • ClinicalTrials.gov/NCT02383732